You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 589 Efficacy of oncolytic vaccinia virus requires infection of suppressive immune cells in the tumor microenvironment leading to their reprogramming and deletion

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immune-stimulants and immune modulators
589 Efficacy of oncolytic vaccinia virus requires infection of suppressive immune cells in the tumor microenvironment leading to their reprogramming and deletion

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 202089012
Dec 202027013
Jan 20212307
Feb 20211004
Mar 20213807
Apr 20212603
May 2021804
Jun 2021006
Jul 2021004
Aug 2021007
Sep 2021004
Oct 202132020
Nov 202114017
Dec 2021400
Jan 20221602
Feb 20221402
Mar 2022600
Apr 20223003
May 20221605
Jun 20221401
Jul 20222003
Aug 20221603
Sep 20221801
Oct 20221402
Nov 20222801
Dec 20221800
Jan 20232001
Feb 20232802
Mar 2023800
Apr 2023602
May 20231203
Jun 20231402
Jul 2023201
Aug 2023400
Sep 2023200
Oct 2023803
Nov 20231602
Dec 20232604
Jan 20242201
Feb 20241600
Mar 20241606
Apr 2024800
May 20243002
Jun 20242002
Jul 20242002
Aug 20241001
Sep 2024806
Oct 20241806
Nov 20241405
Dec 20241006
Jan 2025809
Feb 2025203
Mar 2025008
Apr 2025002
May 2025005
Jun 2025002
Total8290217